Provided by Tiger Fintech (Singapore) Pte. Ltd.

Legend Biotech

33.48
+0.05000.15%
Volume:1.24M
Turnover:41.12M
Market Cap:6.17B
PE:-28.13
High:33.62
Open:33.05
Low:32.80
Close:33.43
Loading ...

Legend Biotech Valuation Presents 'Buying Opportunity,' RBC Analysts Say

MT Newswires Live
·
Yesterday

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Legend Biotech (LEGN), Eli Lilly & Co (LLY) and Exelixis (EXEL)

TIPRANKS
·
23 Jun

Legend Biotech Corporation Concludes Annual General Meeting

Reuters
·
13 Jun

Legend Biotech Corporation Names Peter Salovey as Lead Independent Director

Reuters
·
05 Jun

Legend Biotech Reveals 5-Year Survival Data for CARVYKTI® at ASCO 2025

TIPRANKS
·
03 Jun

Legend Biotech unveils five-year survival data fro CARVYKTI

TIPRANKS
·
03 Jun

Legend Biotech Announces Promising Phase 1 Results for LB2102 CAR-T Therapy in Lung Cancer Patients

Reuters
·
03 Jun

Buy Rating for Legend Biotech Driven by Carvykti’s Market Position and Efficacy

TIPRANKS
·
02 Jun

Legend Biotech’s Carvykti Shows Strong Potential and Undervalued Stock Presents Attractive Investment Opportunity

TIPRANKS
·
02 Jun

Analysts Are Bullish on These Healthcare Stocks: Legend Biotech (LEGN), PTC Therapeutics (PTCT)

TIPRANKS
·
27 May

Exploring High Growth Tech Stocks In The US This May 2025

Simply Wall St.
·
23 May

Analysts Offer Insights on Healthcare Companies: Legend Biotech (LEGN), Merus (MRUS) and Exelixis (EXEL)

TIPRANKS
·
23 May

Legend Biotech to Present New CARVYKTI Data at 2025 ASCO and EHA Meetings

TIPRANKS
·
23 May

Legend Biotech to Reveal New CARVYKTI Data for Multiple Myeloma at 2025 ASCO and EHA Meetings

Reuters
·
23 May

Legend Biotech Announces New Oncologic & Hematologic Therapeutic Developments at ASCO, EHA, and ASGCT

GlobeNewswire
·
23 May

Stock Track | Legend Biotech Soars 5% as Investors Anticipate Key Updates at ASCO Meeting

Stock Track
·
20 May

Stock Track | Legend Biotech Soars 5% as Company Announces Investor Event at ASCO Annual Meeting

Stock Track
·
20 May

Legend Biotech Corporation to Host Investor Event During American Society of Clinical Oncology Annual Meeting

Reuters
·
19 May

Legend Biotech Shares Have 'Meaningful Upside' With Continued Execution, RBC Says

MT Newswires Live
·
16 May

Legend Biotech’s Promising Outlook: Strong Demand, Capacity Expansion, and Market Leadership Drive Buy Rating

TIPRANKS
·
16 May